Mostrar el registro sencillo del ítem

dc.contributor.authorLopez-Jaramillo, Patricio
dc.contributor.authorOtero, Johanna
dc.contributor.authorAlvernia, Juliana
dc.contributor.authorNey-Salazar, Daniela
dc.contributor.authorLopez-Lopez, Jose
dc.contributor.authorAccini, Jose L.
dc.contributor.authorAroca, Gustavo
dc.contributor.authorUrina-Triana, Miguel
dc.contributor.authorSánchez-Vallejo, Gregorio
dc.contributor.authorArcos, Edgar
dc.contributor.authorCasanova, María E.
dc.contributor.authorGarcía, Henry
dc.contributor.authorBeaney, Thomas
dc.contributor.authorChis Ster, Anca
dc.contributor.authorPoulter, Neil R.
dc.description.abstractHigh blood pressure (BP) is the leading global preventable cause of death and the most common risk factor for cardiovascular disease (CVD). However, due to its asymptomatic nature, the lack of awareness of this condition causes underdiagnosis and low rates of adherence to pharmacological treatment. Looking for practical approaches to increase awareness worldwide, the International Society of Hypertension (ISH) implemented the 2nd May Measurement Month campaign in 2018 (MMM18). In order to contribute to this initiative, Colombia participated as one of the 89 countries involved in this hypertension screening programme. Blood pressure was measured in subjects from 11 departments in Colombia. Under the leadership of the Fundacio´n Oftalmolo´gica de Santander (FOSCAL), 400 volunteers across the country collected the data following the MMM protocol. Measurements from 35 548 participants with a mean age of 41.9 years were obtained. In total, 9475 (26.7%) of the total population studied had hypertension. Of those with hypertension, 69.9% of these subjects were aware of their condition, 65.0% were on antihypertensive medication, and 43.1% had controlled BP. Of those on medication, 66.3% had controlled BP. Hypertension screening, awareness, treatment, and control should be a priority in public health objectives due to its elevated burden of disease and direct association with increased CVD. The MMM campaign provided a positive impact in the diagnosis of hypertension across Colombia. Although efforts are being made to expand treatment capability and adherence, still more are needed to insure a broader coverage of antihypertensive medication in Colombia.eng
dc.publisherEuropean Society of Cardiologyeng
dc.rightsAttribution-NonCommercial-NoDerivatives 4.0 Internacional
dc.sourceEuropean Heart Journaleng
dc.sourceVol. 22, Suplemento, (2020)
dc.subjectBlood pressureeng
dc.titleMay measurement month 2018: an analysis of blood pressure screening results from Colombiaeng
dcterms.referencesYusuf S, Joseph P, Rangarajan S, Islam S, Mente A, Hystad P, Brauer M, Kutty VR, Gupta R, Wielgosz A, AlHabib KF, Dans A, Lopez- Jaramillo P, Avezum A, Lanas F, Oguz A, Kruger IM, Diaz R, Yusoff K, Mony P, Chifamba J, Yeates K, Kelishadi R, Yusufali A, Khatib R, Rahman O, Zatonska K, Iqbal R, Wei L, Bo H, Rosengren A, Kaur M, Mohan V, Lear SA, Teo KK, Leong D, O’Donnell M, McKee M, Dagenais G. Modifiable risk factors, cardiovascular disease, and mortality in 155 722 individuals from 21 high-income, middle-income, and lowincome countries (PURE): a prospective cohort study. Lancet 2020; 395:795–808.eng
dcterms.referencesThe GBD 2016 Lifetime Risk of Stroke Collaborators. Global, regional, and national burden of cardiovascular diseases for 10 causes, 1990 to 2015. J Am Coll Cardiol 2017;70:1–25.eng
dcterms.referencesOlsen MH, Angell SY, Asma S, Boutouyrie P, Burger D, Chirinos JA, Damasceno A, Delles C, Gimenez-Roqueplo A-P, Hering D, Lo´pez- Jaramillo P, Martinez F, Perkovic V, Rietzschel ER, Schillaci G, Schutte AE, Scuteri A, Sharman JE, Wachtell K, Wang JG. A call to action and a lifecourse strategy to address the global burden of raised blood pressure on current and future generations: the Lancet Commission on hypertension. Lancet 2016;388:2665–2712.eng
dcterms.referencesWHO. NCD and the Sustainable Development Goals. WHO. 2016. sustainable-development-goals/en/ (1 October 2019).eng
dcterms.referencesLopez-Jaramillo P, Otero J, Rueda-Quijano SM, Camacho PA, Rey JJ, Sanchez G, Narva´ez C, Accini JL, Arcos E, Garcı´a H, Pe´rez M, Aroca G, Beaney T, Kobeissi E, Poulter NR. May Measurement Month 2017: an analysis of blood pressure screening results in Colombia- Americas. Eur Heart J Suppl 2019;21(Suppl D):D40–D43.eng
dcterms.referencesAcu~na L, Soler LA, Valderrama F, Daza MT, Pe´rez AV, Fuentes JC, Quintero A, Santacruz JC, Barbosa P, Castillo A, Bogoya A, Va´squez MV. Dı´a mundial de la Hipertensio´n. Boletı´n Inf Te´cnica Espec la cuenta alto costo 2018;4:3–5.eng
dcterms.referencesBeaney T, Burrell LM, Castillo RR, Charchar FJ, Cro S, Damasceno A, Kruger R, Nilsson PM, Prabhakaran D, Ramirez AJ, Schlaich MP, Schutte AE, Tomaszewski M, Touyz R, Wang J-G, Weber MA, Poulter NR; the MMM Investigators. May Measurement Month 2018: a pragmatic global screening campaign to raise awareness of blood pressure by the International Society of Hypertension. Eur Heart J 2019; 40:2006–2017.eng
dcterms.referencesHuffman MD, Labarthe DR, Yusuf S. Global cardiovascular research training for implementation science, health systems research, and health policy research. J Am Coll Cardiol 2015;65:1371–1372.eng
dcterms.referencesSchwalm JD, McCready T, Lo´pez-Jaramillo P, Yusoff K, Attaran A, Lamelas P, Camacho PA, Majid F, Bangdiwala SI, Thabane L, Islam S, Mckee M, Yusuf S. A community-based comprehensive intervention to reduce cardiovascular risk in hypertension (HOPE 4): a clusterrandomised controlled trial. Lancet 2019;394:1231–1242.eng
dcterms.referencesLo´pez-Jaramillo P, Barbosa E, Molina DI, Sanchez R, Diaz M, Camacho PA, Lanas F, Pasquel M, Accini JL, Ponte-Negretti CI, Alcocer L, Cobos L, Wyss F, Sebba-Barroso W, Coca A, Zanchetti A. Latin American Consensus on the management of hypertension in the patient with diabetes and the metabolic syndrome. J Hypertens 2019; 37:1126–1147.eng
dcterms.referencesHaeusler KG, Huttner HB, Kuramatsu JB. Comment on 2018 ESC/ESH Guidelines for the management of arterial hypertension. Eur Heart J 2019;40:2092–2092.eng
dcterms.referencesDagenais GR, Leong DP, Rangarajan S, Lanas F, Lo´pez-Jaramillo P, Gupta R, Diaz R, Avezum A, Oliveira G, Wielgosz A, Parambath S, Mony P, Alhabib K, Temizhan A, Ismail N, Chifamba J, Yeates K, Khatib R, Rahman O, Zatonska K, Kazmi K, Wei L, Zhu J, Rosengren A, Vijayakumar K, Kaur M, Mohan V, Yusufali A, Kelishadi R, Teo KK, Joseph P, Yusuf S. Variations in common diseases, hospital admissions, and deaths in middle-aged adults in 21 countries from five continents (PURE): a prospective cohort study. Lancet 2020;395: 785–794.eng
dc.type.spaArtículo científicospa

Ficheros en el ítem


Este ítem aparece en la(s) siguiente(s) colección(ones)

  • Artículos
    Artículos científicos evaluados por pares

Mostrar el registro sencillo del ítem

Attribution-NonCommercial-NoDerivatives 4.0 Internacional
Excepto si se señala otra cosa, la licencia del ítem se describe como Attribution-NonCommercial-NoDerivatives 4.0 Internacional